Betterthangold
:
They had 1/3 of a clinical trial not provide protection against severe cases of C-19 with their ingestible treatment. There was an overreaction and sell off. Look at the stock prices of AVIR over the 16-18 months. This is a solid $30-50+ stock and a solid company ran by Dr’s. They’re still continuing clinical trials seeking to treat severe cases of viral infections orally. I think by the end of the year this will rebound and be up 100% or higher.
Betterthangold : They had 1/3 of a clinical trial not provide protection against severe cases of C-19 with their ingestible treatment. There was an overreaction and sell off. Look at the stock prices of AVIR over the 16-18 months. This is a solid $30-50+ stock and a solid company ran by Dr’s. They’re still continuing clinical trials seeking to treat severe cases of viral infections orally. I think by the end of the year this will rebound and be up 100% or higher.
Typ OP Betterthangold : So need to keep the stock until end of the years? What do you think how much per/value by then.
Typ OP Betterthangold : How much the stock per/value you holding?
TyagiPratt : Down
Typ OP TyagiPratt : Let go listen a song (Jay Sean - Down ft. Lil Wayne)